ArticleJournal of the Society for Cardiovascular Angiography & Interventions2026
Impact of Social Determinants of Health on Utilization of Mechanical Circulatory Support Device in STEMI With Cardiogenic Shock.
Article in Journal of the Society for Cardiovascular Angiography & Interventions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mechanical Circulatory Support on Coronary Artery Bypass Grafting for Advanced Ischemic Cardiomyopathy: State of the Art.Medicina (Kaunas, Lithuania) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Background: Cardiogenic shock (CS) is a severe complication of ST-elevation myocardial infarction (STEMI) with high mortality despite advancements in treatment. Mechanical circulatory support (MCS) devices, such as extracorporeal membrane oxygenation, Impella, and intraaortic balloon pump, have shown promise in improving outcomes but remain underutilized, especially among minority populations and women. This study evaluated disparities in MCS utilization among STEMI-CS patients based on sex, race, and socioeconomic factors. Methods: We analyzed data from the Nationwide Inpatient Sample between 2016 and 2021, identifying patients with STEMI-CS using International Classification of Diseases, Tenth Revision codes. Patients were stratified based on MCS utilization. Sociodemographic and hospital characteristics were compared, and multivariate logistic regression and propensity score matching were applied to evaluate disparities and outcomes. Results: Among 140,820 patients with STEMI-CS, 18.8% received MCS. MCS recipients were younger, predominantly male (74.2% vs 65.1%; Conclusions: This study highlights significant disparities in MCS utilization among STEMI-CS patients, driven by sex, race, and socioeconomic factors. These findings underscore the need for targeted interventions to address health care inequities and improve outcomes in this high-risk population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.